BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22615843)

  • 1. Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.
    Chiantore MV; Vannucchi S; Accardi R; Tommasino M; Percario ZA; Vaccari G; Affabris E; Fiorucci G; Romeo G
    PLoS One; 2012; 7(5):e36909. PubMed ID: 22615843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.
    Accardi R; Dong W; Smet A; Cui R; Hautefeuille A; Gabet AS; Sylla BS; Gissmann L; Hainaut P; Tommasino M
    EMBO Rep; 2006 Mar; 7(3):334-40. PubMed ID: 16397624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-β antiproliferative effect and miRNA regulation in Human Papilloma Virus E6- and E7-transformed keratinocytes.
    Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Fiorucci G; Romeo G
    Cytokine; 2017 Jan; 89():235-238. PubMed ID: 26748726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
    Pacini L; Ceraolo MG; Venuti A; Melita G; Hasan UA; Accardi R; Tommasino M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.
    Bischof O; Nacerddine K; Dejean A
    Mol Cell Biol; 2005 Feb; 25(3):1013-24. PubMed ID: 15657429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 or p73 in human papillomavirus type 38 E6 and E7 transgenic mice partially restores the UV-activated cell cycle checkpoints.
    Dong W; Arpin C; Accardi R; Gissmann L; Sylla BS; Marvel J; Tommasino M
    Oncogene; 2008 May; 27(20):2923-8. PubMed ID: 18026133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
    Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M
    J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
    Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
    Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
    Dacus D; Cotton C; McCallister TX; Wallace NA
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
    Hebner C; Beglin M; Laimins LA
    J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.
    Fischer M; Uxa S; Stanko C; Magin TM; Engeland K
    Sci Rep; 2017 Jun; 7(1):2603. PubMed ID: 28572607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells.
    Kim KS; Kang KW; Seu YB; Baek SH; Kim JR
    Mech Ageing Dev; 2009 Mar; 130(3):179-88. PubMed ID: 19071156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 38 alters wild-type p53 activity to promote cell proliferation via the downregulation of integrin alpha 1 expression.
    Romero-Medina MC; Venuti A; Melita G; Robitaille A; Ceraolo MG; Pacini L; Sirand C; Viarisio D; Taverniti V; Gupta P; Scalise M; Indiveri C; Accardi R; Tommasino M
    PLoS Pathog; 2020 Aug; 16(8):e1008792. PubMed ID: 32813746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
    Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
    Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of cutaneous oncoprotein HPVE6 by wtp53, mutant p53R248W and ΔNp63α is HPV type dependent.
    Fei JW; de Villiers EM
    PLoS One; 2012; 7(4):e35540. PubMed ID: 22530045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
    DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
    Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.